Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland
Files
(Published version)
Date
2022
Authors
Bandiera, C.
Skrabal Ross, X.
Cardoso, E.
Wagner, D.
Csajka, C.
Olver, I.
Patterson, P.
Suppiah, V.
Gunn, K.M.
Schneider, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Supportive Care in Cancer, 2022; 30(5):3655-3659
Statement of Responsibility
Conference Name
Abstract
Not monitoring adherence to oral anticancer therapies (OAT) can lead to poor clinical outcomes, including premature death as reported by Foulon et al. (Acta Clin Belg 66(2):85–96, 2011) and Greer et al. (Oncologist 21(3):354–76, 2016). Barriers to the implementation of supportive cancer care interventions in medication adherence occur with multiple hospital sites, cancer diagnoses, and numerous healthcare professionals. This commentary describes challenges and strategies from two OAT adherence trials in Australia and Switzerland to assist researchers in the design and implementation of future interprofessional trials.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2021 The Authors, under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature